Partial
Partially Aligned
Patient Risk:
Moderate
Summary
Partially aligned: grapefruit juice and increased atorvastatin plasma concentrations are supported. However, the key counseling claim to 'avoid grapefruit berries and their juice in any form' is not supported by the provided label text and is treated as a contradiction by the evaluator.
Category Scores
Accurate Statements
Grapefruit juice contains components that inhibit CYP 3A4 and can increase plasma concentrations of atorvastatin (especially with excessive grapefruit juice consumption >1.2 liters/day).
Label 7.2 Grapefruit Juice.
Increased atorvastatin exposure can be associated with skeletal muscle adverse reactions such as muscle aches/weakness (myopathy) and rare rhabdomyolysis.
Label 5.1 Skeletal Muscle; and linkage in 7.2 to increased plasma concentrations.
Statins can be associated with biochemical abnormalities of liver function and liver enzyme testing/monitoring is recommended around initiation and dose increases.
Label 5.2 Liver Dysfunction; and adverse reactions referenced in section 6 and Warnings/Precautions 5.2.
Unsupported Statements
Grapefruit juice contains furanocoumarins.
The provided label section 7.2 does not identify furanocoumarins; it only states grapefruit juice components inhibit CYP3A4.
Increased Lipitor concentration in the bloodstream can lead to increased side effects such as liver damage.
The label supports liver enzyme abnormalities and monitoring, but the provided excerpts do not explicitly connect grapefruit-mediated increased concentrations to liver damage.
Other berries like orange may also interact with Lipitor.
No supporting label text in the provided sections.
Bergamot may also interact with Lipitor.
No supporting label text in the provided sections.
Tangerine and lemon may also interact with Lipitor to a lesser extent.
No supporting label text in the provided sections.
The extent of interaction between Lipitor and berries other than grapefruit varies.
No supporting label text in the provided sections.
Patients taking Lipitor should limit or avoid consuming other berries that may interact with Lipitor.
No supporting label text in the provided sections.
Patients taking Lipitor should consult their healthcare provider before consuming any juice or supplement.
The provided label excerpts do not support a blanket instruction about any juice or supplement; section 17 is more specific to substances not taken concomitantly and informing healthcare professionals.
Contradictions
Low
AI Statement
Patients taking Lipitor should avoid grapefruit berries and their juice in any form.
Label Reference
Label 7.2 Grapefruit Juice.
Important Omissions
The label-supported counseling is about excessive grapefruit juice consumption (>1.2 liters/day) and increased plasma concentrations; the AI response does not reflect the label’s emphasis/threshold wording.
Importance:
Moderate
Label-supported guidance regarding monitoring and actions for muscle and liver issues (e.g., reporting unexplained muscle pain/weakness; liver function tests prior to and at 12 weeks after initiation and with dose increases) is not clearly and accurately incorporated in the AI claims set as provided.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
The grapefruit interaction direction is partially correct (increased atorvastatin exposure), but the overbroad instruction to avoid grapefruit 'in any form' is not label-aligned and several claims about other fruits/supplements are unsupported, which could mislead patients. Missing label nuance and monitoring instructions further reduces alignment.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Partially Aligned
Primary Issue
Overreaching/contradictory counseling: advising avoidance of grapefruit berries and juice 'in any form' is not supported by the provided label section 7.2. Additional unsupported fruit interaction claims are included.
Suggested Improvement
Limit counseling to what the label states in 7.2: grapefruit juice contains components that inhibit CYP3A4 and can increase atorvastatin plasma concentrations, especially with excessive grapefruit juice consumption (>1.2 liters/day). If discussing adverse outcomes, tie them to the label’s described risks (e.g., myopathy/rhabdomyolysis symptoms and liver enzyme abnormalities with recommended monitoring) without adding unsupported fruit-specific interactions.